Clinical trials
Recruiting Observational Hyperlipoproteinemia Type II trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Hospital of Fudan University | 1 |
| Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | 1 |
| Fundación Hipercolesterolemia Familiar | 1 |
| Hospital do Coracao | 1 |
| Imperial College London | 1 |
| Institut Investigacio Sanitaria Pere Virgili | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Novartis Pharmaceuticals | 1 |
| Polish Mother Memorial Hospital Research Institute | 1 |
| Russian Cardiology Research and Production Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 11 |
| Atherosclerosis | 2 |
| Cardiovascular Diseases | 2 |
| Genetic Diseases, Inborn | 2 |
| Aortic Coarctation | 1 |
| Aortic Valve Stenosis | 1 |
| Arrhythmogenic Right Ventricular Dysplasia | 1 |
| Brugada Syndrome | 1 |
| Cardiomyopathy, Dilated | 1 |
| Cardiomyopathy, Hypertrophic | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.